X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
building (12) 12
fixed constructions (12) 12
performing operations (9) 9
transporting (9) 9
humans (8) 8
index medicus (8) 8
physics (7) 7
building implements or other building aids, or theiruse (6) 6
forms (6) 6
handling building materials on the site (6) 6
male (6) 6
repairing, breaking-up or other work on existingbuildings (6) 6
scaffolding (6) 6
shuttering (6) 6
buildings or like structures for particular purposes (5) 5
fatty acids (5) 5
female (5) 5
fencing (5) 5
masts (5) 5
physics, condensed matter (5) 5
swimming or splash baths or pools (5) 5
tents or canopies, in general (5) 5
aged (4) 4
cardiovascular diseases (4) 4
cardiovascular diseases - prevention & control (4) 4
diabetes mellitus, type 2 - drug therapy (4) 4
follow-up studies (4) 4
insulin (4) 4
insulin glargine (4) 4
machine tools (4) 4
mathematics (4) 4
metal-working not otherwise provided for (4) 4
middle aged (4) 4
phenomenological description (4) 4
proportional hazards models (4) 4
relaxation processes (4) 4
research (4) 4
animals (3) 3
cardiovascular disease (3) 3
care and treatment (3) 3
chemistry (3) 3
cholesterol (3) 3
diabetes (3) 3
diabetes mellitus, type 2 - complications (3) 3
electricity (3) 3
food science & technology (3) 3
insulin, long-acting (3) 3
life sciences (3) 3
management (3) 3
measuring (3) 3
medicine, general & internal (3) 3
risk (3) 3
testing (3) 3
treatment outcome (3) 3
[ sdv ] life sciences [q-bio] (2) 2
abridged index medicus (2) 2
amino acids - metabolism (2) 2
amyloid beta-peptides - antagonists & inhibitors (2) 2
amyloid beta-peptides - toxicity (2) 2
analysis (2) 2
article (2) 2
biochemistry & molecular biology (2) 2
blood glucose - analysis (2) 2
brain (2) 2
capacitors (2) 2
cardiac & cardiovascular systems (2) 2
cardiovascular diseases - etiology (2) 2
causes of (2) 2
ceilings (2) 2
cellular and molecular neuroscience (2) 2
chemistry, multidisciplinary (2) 2
cholesterol - blood (2) 2
clinical trials (2) 2
combinations or associations of metal-working machines, notdirected to a particular result (2) 2
complications and side effects (2) 2
conversion or distribution of electric power (2) 2
coronary-heart-disease (2) 2
details, components, or accessories for machine tools, e.g.arrangements for copying or controlling (2) 2
diabetes mellitus (2) 2
diabetes mellitus, type 2 (2) 2
dietary supplements (2) 2
differentiation basis (2) 2
dihydroxyacetone phosphate (2) 2
double-blind method (2) 2
drug therapy, combination (2) 2
dyadic rectangles (2) 2
endothelial function (2) 2
environmental sciences (2) 2
fatty acids, omega-3 (2) 2
fatty acids, omega-3 - therapeutic use (2) 2
floors (2) 2
general building constructions (2) 2
generation (2) 2
glucose (2) 2
glucose intolerance (2) 2
glucose intolerance - complications (2) 2
glucose intolerance - drug therapy (2) 2
glucose tolerance (2) 2
glycerokinase (2) 2
glycerophosphate (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
by Bosch, Jackie and Gerstein, Hertzel C and Dagenais, Gilles R and Díaz, Rafael and Dyal, Leanne and Jung, Hyejung and Maggiono, Aldo P and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, Leanne and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 309 - 318
Participants with impaired fasting glucose who were at risk for cardiovascular events were assigned to receive daily n−3 fatty acids or placebo and to receive... 
MEDICINE, GENERAL & INTERNAL | EVENTS | PREVENTION | FISH | RISK | CORONARY-HEART-DISEASE | OMEGA-3-FATTY-ACID INTAKE | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Treatment Failure | Cardiovascular Diseases - mortality | Female | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Double-Blind Method | Proportional Hazards Models | Glucose Intolerance - complications | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Prevention | Complications and side effects | Care and treatment | Patient outcomes | Dietary supplements | Causes of | Diabetes | Cardiovascular diseases | Fatty acids | Health aspects | Myocardial infarction | Arrhythmia | Diabetes mellitus | Lipids | Esters | Cardiovascular disease | Insulin | Glucose tolerance | Diet | Death | Supplementation | Diabetes mellitus (non-insulin dependent) | Heart diseases | Cardiovascular Diseases | Insulin, Long-Acting | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article